On June 3, 2022 Cytokinetics, Incorporated (Nasdaq: CYTK) reported that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in the following investor conferences (Press release, Cytokinetics, JUN 3, 2022, View Source [SID1234615522]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Healthcare Conference on Thursday, June 9, 2022 at 10:00 AM ET in a presentation at the Marriott Marquis Hotel in New York City
Goldman Sachs 43rd Annual Healthcare Conference on Monday, June 13, 2022 at 2:40 PM PT in a fireside chat at the Terranea Resort in Rancho Palos Verdes
JMP Securities Life Sciences Conference on Wednesday, June 15, 2022 at 3:00 PM ET in a fireside chat at the Lotte New York Palace in New York City
Interested parties may access the live webcast of these presentations by visiting the Investors & Media section of the Cytokinetics website at www.cytokinetics.com. The webcast replay will be archived on the Presentations page within the Investors & Media section of Cytokinetics’ website for 90 days following the conclusion of the event.